A Multicenter Randomized Controlled Open-label Trial of Tenofovir vs. Tenofovir Plus Entecavir in Chronic Hepatitis B Patients With Genotypic Resistance to Entecavir and Partial Virologic Response to Ongoing Treatment
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Feb 2018
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- 18 Feb 2018 Planned End Date changed from 1 Jun 2018 to 1 Apr 2018.
- 18 Feb 2018 Planned primary completion date changed from 1 Jun 2014 to 1 Apr 2018.
- 24 Jun 2015 Planned End Date changed from 1 Jun 2014 to 1 Jun 2018 as reported by ClinicalTrials.gov.